Literature DB >> 13031444

Clinical studies of phenylbutazone (butazolidin) and butapyrin (irgapyrin) in rheumatoid arthritis, rheumatoid spondylitis, and gout.

E G KIDD, K C BOYCE, R H FREYBERG.   

Abstract

Entities:  

Keywords:  ANALGESICS/therapeutic use; ARTHRITIS, RHEUMATOID/therapy; GOUT/therapy; SPONDYLITIS

Mesh：

Substances：

Year:  1953        PMID： 13031444      PMCID： PMC1030429          DOI： 10.1136/ard.12.1.20

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Phenylbutazone therapy of arthritis and other painful musculoskeletal disorders.

Authors:  O STEINBROCKER; S BERKOWITZ; M EHRLICH; M ELKIND; S CARP
Journal:  J Am Med Assoc       Date:  1952-11-15

2.  [Effect of irgapyrine on salt and water metabolism and on renal function].

Authors:  J FABRE; R S MACH
Journal:  Schweiz Med Wochenschr       Date:  1951-05-19

3.  [Irgapyrine in rheumatic diseases].

Authors:  H SELIGER
Journal:  Arztl Wochensch       Date:  1951-01-26

4.  [On irgapyrine, a new drug in parenteral pyrazol therapy of rheumatic polyarthritis].

Authors:  H FISCHER
Journal:  Dtsch Med Wochenschr       Date:  1951-01-12       Impact factor: 0.628

5.  [Antihistamine effect of the pyrazoles as compared with certain antihistamine preparations].

Authors:  R JAQUES; R DOMENJOZ
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1950

6.  Diseases of bones and joints.

Authors:  W C KUZELL
Journal:  Annu Rev Med       Date:  1951       Impact factor: 13.739

7.  Treatment of rheumatoid arthritis with butazolidine .

Authors:  J P CURRIE
Journal:  Lancet       Date:  1952-07-05       Impact factor: 79.321

8.  Phenylbutazone (butazolidin) in rheumatoid arthritis and gout.

Authors:  W C KUZELL; R W SCHAFFARZICK; B BROWN; E A MANKLE
Journal:  J Am Med Assoc       Date:  1952-06-21

9.  Agranulocytosis following use of phenylbutazone (butazolidin).

Authors:  E BERSHOF; A C OXMAN
Journal:  J Am Med Assoc       Date:  1953-02-14

10.  Benefits and toxicity of phenylbutazone (butazolidin) in rheumatoid arthritis.

Authors:  C A L STEPHENS; E E YEOMAN; W P HOLBROOK; D F HILL; W L GOODIN
Journal:  J Am Med Assoc       Date:  1952-11-15
  10 in total
  5 in total

1.  Recent advances in rheumatic diseases.

Authors:  E W BOLAND
Journal:  Calif Med       Date:  1955-02

2.  The effect of phenylbutazone on uric acid metabolism in two normal subjects.

Authors:  J B WYNGAARDEN
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808

3.  Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects.

Authors:  T F YU; J H SIROTA; A B GUTMAN
Journal:  J Clin Invest       Date:  1953-11       Impact factor: 14.808

4.  Evaluation of phenylbutazone (butazolidin) in the treatment of rheumatoid spondylitis: report of 50 cases.

Authors:  E C TOONE; W R IRBY
Journal:  Trans Am Clin Climatol Assoc       Date:  1953

5.  Do NSAIDs Take Us Away From Treatment Goals in Axial Spondyloarthritis: A Story About Dysbiosis or Just a Matter of Bias?

Authors:  Rubén Queiro-Silva; Andrea García-Valle; Sara Alonso-Castro; Mercedes Alperi-López
Journal:  Front Med (Lausanne)       Date:  2021-12-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.